Recent content by booga82

Regarding the new share issue. its a hefting dilution, by my calc another 147 million shares being added to the 230 million on offer. thats almost 40% dilution. the sp is about 10 cents (being generous) so (1-0.4)x10 cents = 6 cents. im suprised the offer price isnt less than 6.8 cents. i...

Looked at this stock a while ago. The ReCell product is good. Several problems though. Its not approved in the US yet. Its expensive and not a life saving treatment as it is for burns to less than 2% of the body, so basically for aesthetic purposes. Which means it will be unlikely to make...

I was referring to this ann. uploaded on the 18th September regarding E1 East results. "The current program, commencing with EMMD013 (see Figure 2), will test the geometry and true thickness to allow calculation of a JORC inferred resource within the next few weeks."

any idea when this ann. is coming out??? I thought it was going to be a "few weeks"...four weeks ago.

Re: CRJ - Copper Range Sorry thats $9m (undiluted), $19m (diluted). My trading account shows only 18m FPS. Any ideas why? It probably is $21m (undiluted) like you said. any opinions on where this one is heading? cheers.

Re: CRJ - Copper Range Ltd Initial results are expected in Mid october, probably next week given the current interest. Company stated "visible copper mineralisation is evident in many of the holes, both as oxide and sulphide" Has a market cap of $9 million (@53 cps) so opportunity for...

does anyone have any views on this stock? Its shares are down a fair bit and its strategic review is supposed to be coming out on the 25th Sept.

they recently issued options to the executives, which i think were just out of the money. perhaps some good news is on the horizon??? im looking to get in around 20-22.

Everyone knows its all hype with no substance. Fortunately, in the short run, "hype" is the fastest way to make money. PS- does anyone know what inferred resources look like. I think I found some in my backyard.

Generic pharmaceuticals.